Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Payables (2016 - 2026)

Insmed's Payables history spans 17 years, with the latest figure at $352.6 million for Q1 2026.

  • Quarterly Payables rose 51.52% to $352.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $352.6 million through Mar 2026, up 51.52% year-over-year, with the annual reading at $456.1 million for FY2025, 59.9% up from the prior year.
  • Payables came in at $352.6 million for Q1 2026, down from $456.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $456.1 million in Q4 2025 to a low of $31.1 million in Q2 2022.
  • The 5-year median for Payables is $215.0 million (2023), against an average of $232.0 million.
  • Year-over-year, Payables rose 0.2% in 2022 and then skyrocketed 534.64% in 2023.
  • Insmed's Payables stood at $182.1 million in 2022, then grew by 18.05% to $215.0 million in 2023, then surged by 32.66% to $285.2 million in 2024, then skyrocketed by 59.9% to $456.1 million in 2025, then fell by 22.7% to $352.6 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Payables are $352.6 million (Q1 2026), $456.1 million (Q4 2025), and $409.8 million (Q3 2025).